Charles River Labs buys Worcester, MA-based CRO for $64M

• Charles River Laboratories (NYSE:CRL) acquires Agilux Laboratories for $64M in cash subject to certain closing adjustments. The Worcester, MA-based contract research organization (CRO) provides a range of integrated small and large molecule bioanalytical services, drug metabolism and pharmacokinetic services and pharmacology services.
• The transaction should be neutral to CRL's Q4 non-GAAP earnings and slightly accretive in 2017. Agilux's top line should be ~$27M this year.